Literature DB >> 15256235

Immediate breast reconstruction does not lead to a delay in the delivery of adjuvant chemotherapy.

C R Wilson1, I M Brown, E Weiller-Mithoff, W D George, J C Doughty.   

Abstract

Immediate breast reconstruction (IBR) has been considered by some to lead to a delay in the delivery of adjuvant chemotherapy. Our aim was to determine whether IBR led to a delay when compared to conservation surgery and non-reconstructive mastectomy. Ninety-five cases of IBR receiving chemotherapy were reviewed. These were compared to 95 consecutively treated patients undergoing conservation surgery and 95 undergoing non-reconstructive mastectomy. Our data shows that IBR does not lead to a delay in the delivery of adjuvant chemotherapy when compared to standard non-reconstructive surgery and should not adversely affect breast cancer outcome.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15256235     DOI: 10.1016/j.ejso.2004.04.006

Source DB:  PubMed          Journal:  Eur J Surg Oncol        ISSN: 0748-7983            Impact factor:   4.424


  14 in total

Review 1.  Is there any argument for delayed breast reconstruction after total mastectomy?

Authors:  Michael J Greenall
Journal:  Ann R Coll Surg Engl       Date:  2007-11       Impact factor: 1.891

Review 2.  Breast reconstruction: current and future options.

Authors:  Henry Paul; Tahira I Prendergast; Bryson Nicholson; Shenita White; Wayne Ai Frederick
Journal:  Breast Cancer (Dove Med Press)       Date:  2011-08-17

3.  Skin-reducing Mastectomy with Primary Implant Reconstruction.

Authors:  W Siggelkow; K Lübbe; J Gade; H Kölbl; M Schmidt; D Böhm
Journal:  Geburtshilfe Frauenheilkd       Date:  2012-07       Impact factor: 2.915

4.  The impact of breast reconstruction on the delivery of chemotherapy.

Authors:  Amy K Alderman; E Dale Collins; Anne Schott; Melissa E Hughes; Rebecca A Ottesen; Richard L Theriault; Yu-Ning Wong; Jane C Weeks; Joyce C Niland; Stephen B Edge
Journal:  Cancer       Date:  2010-04-01       Impact factor: 6.860

5.  Impact of neoadjuvant chemotherapy on breast reconstruction.

Authors:  Yue-Yung Hu; Christine M Weeks; Haejin In; Christopher M Dodgion; Mehra Golshan; Yoon S Chun; Michael J Hassett; Katherine A Corso; Xiangmei Gu; Stuart R Lipsitz; Caprice C Greenberg
Journal:  Cancer       Date:  2011-01-24       Impact factor: 6.860

6.  Does Immediate Breast Reconstruction after Mastectomy affect the Initiation of Adjuvant Chemotherapy?

Authors:  Jeonghui Lee; Se Kyung Lee; Sangmin Kim; Min Young Koo; Min-Young Choi; Soo Youn Bae; Dong Hui Cho; Jiyoung Kim; Seung Pil Jung; Jun-Ho Choe; Jung-Han Kim; Jee Soo Kim; Jeong Eon Lee; Jung-Hyun Yang; Seok Jin Nam
Journal:  J Breast Cancer       Date:  2011-12-27       Impact factor: 3.588

Review 7.  Patients opting for breast reconstruction following mastectomy: an analysis of uptake rates and benefit.

Authors:  Marissa M Howard-McNatt
Journal:  Breast Cancer (Dove Med Press)       Date:  2013-02-25

8.  The iBRA-2 (immediate breast reconstruction and adjuvant therapy audit) study: protocol for a prospective national multicentre cohort study to evaluate the impact of immediate breast reconstruction on the delivery of adjuvant therapy.

Authors:  Rajiv Dave; Rachel O'Connell; Tim Rattay; Zoe Tolkien; Nicola Barnes; Joanna Skillman; Paula Williamson; Elizabeth Conroy; Matthew Gardiner; Adrian Harnett; Ciara O'Brien; Jane Blazeby; Shelley Potter; Chris Holcombe
Journal:  BMJ Open       Date:  2016-10-07       Impact factor: 2.692

Review 9.  The effect of immediate breast reconstruction on the timing of adjuvant chemotherapy: a systematic review.

Authors:  J Xavier Harmeling; Casimir A E Kouwenberg; Eveline Bijlard; Koert N J Burger; Agnes Jager; Marc A M Mureau
Journal:  Breast Cancer Res Treat       Date:  2015-08-19       Impact factor: 4.872

10.  Patient's Education Before Mastectomy Influences the Rate of Reconstructive Surgery.

Authors:  R Tarkowski; K Szmigiel; A Rubin; G Borowiec; J Szelachowska; W Jagodziński; M Bębenek
Journal:  J Cancer Educ       Date:  2017-09       Impact factor: 2.037

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.